Publication:


abstract

We report a Lateral rectus muscle paralysis occurring 2 weeks after initiation of an interferon-α and ribavirin treatment in a patient with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) virus co-infection. This patient presented with horizontal diplopia that appeared rapidly and without any other neurological symptoms. Symptoms fully resolved with treatment interruption without any ophthalmological sequelae. This side effect is rare and has never been reported in a HIV-HCV co-infected patient.

Related Articles
Review Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.
Int J Nanomedicine. 2006
Review Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.
Zoller H, Vogel W. Int J Nanomedicine. 2006; 1(4):399-409.
Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.
J Viral Hepat. 2007
Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.
Tural C, Solà R, Rubio R, Santín M, Planas R, Quereda C, Berenguer J, Montes-Ramírez M, Clotet B, and the CORAL-1 study group. J Viral Hepat. 2007 Oct; 14(10):704-13.
[Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
Zhonghua Gan Zang Bing Za Zhi....
[Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
Zheng YH, He Y, Yang X, Gong GZ, Zhou HY, Zhang CY, Zhou W, Huang L, Ding PP, Li H. Zhonghua Gan Zang Bing Za Zhi. 2005 Oct; 13(10):741-4.
Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
Antivir Ther. 2011
Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
Tural C, Solà R, Alvarez NP, Moltó J, Sánchez M, Zamora AM, Ornelas A, Laguno M, González J, von Wichmann MÁ, et al. Antivir Ther. 2011; 16(6):833-41.
Review [HIV and hepatitis C co-infection].
Dtsch Med Wochenschr. 2010
Review [HIV and hepatitis C co-infection].
Vogel M, Boesecke C, Wasmuth JC, Rockstroh JK. Dtsch Med Wochenschr. 2010 Jun; 135(23):1186-91. Epub 2010 May 31.